SecBot SecBot
8-K ·Filed Apr 7, 2026

COLL

COLLEGIUM PHARMACEUTICAL, INC
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001628280-26-024061
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for any shifts in board dynamics or strategic direction ahead of the 2026 Annual Meeting, but no trading catalyst expected from this routine governance update.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$33.43
T+0 close · Apr 7, 2026 · via day close
Latest settled
+10.77%
T+60 · $37.03
Vs SPY
+0.31%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 8 $33.43entry
  2. T+1 · 7mo ago +5.44%α +4.87% · $35.25
  3. T+5 · 7mo ago +4.49%α +0.97% · $34.93
  4. T+20 · 7mo ago +5.65%α −2.89% · $35.32
  5. T+60 · 4mo ago +10.77%α +0.31% · $37.03
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Collegium Pharmaceutical announced the nomination of Michael Donovan to its board of directors and the retirement of director John Fallon at the 2026 Annual Meeting. Fallon's departure is part of board refreshment and not due to disagreement.

Key Facts

  • Michael Donovan, former EY audit partner with life sciences expertise, nominated to board
  • Dr. John Fallon to retire from board after serving since 2016
  • No CEO/CFO departure or executive change involved
  • Board refreshment cited as reason for transition

Financial Impact

No immediate financial impact disclosed

governanceboard composition

Risk Factors

  • Potential loss of medical expertise with Dr. Fallon's departure
  • Board transition risk if new member lacks industry-specific experience

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-024061
Document: 0001628280-26-024061-index-headers.html0001628280-26-024061
Document: 0001628280-26-024061-index.html0001628280-26-024061
Document: 0001628280-26-024061.txt0001628280-26-024061

Track record

24 reports on COLL

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +0.28% at T+1 after the Aug 13, 2026 report. 1 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $25.68 Now $25.43 −0.97% settles Nov 17
  2. Nov 10, 20266d ago SC 13G/A Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
  3. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $24.47 to $24.81 Now $25.43 +3.92% ▲ +1.39% +0.07% vs SPY
  4. Nov 9, 20267d ago Institutional Cluster Bearish 4/10 Entry $24.47 to $24.81 Now $25.43 −3.92% ▼ −1.39% −0.07% vs SPY
  5. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  6. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $25.16 to $24.21 Now $25.43 +1.07% ▼ −3.78% −4.09% vs SPY
  7. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $23.80 to $23.68 Now $25.43 +6.85% ▼ −0.50% −0.03% vs SPY
  8. Oct 29, 202618d ago SC 13G/A Neutral 3/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
  9. Oct 29, 202618d ago Press Release Neutral 2/10 Entry $24.03 to $23.80 Now $25.43 +5.83% ▼ −0.96% +0.82% vs SPY
  10. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $23.50 to $22.96 Now $25.43 +8.21% ▼ −2.30% −1.78% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens in 6h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 7, 2026